Multi-Omics Profiling of Myocardial Stunning and Necrosis across Experimental and Clinical Settings
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
This thesis investigates the molecular basis of ischemic preconditioning (IPC)-induced cardioprotection and the mechanisms behind the reversible post-ischemic dysfunction (termed myocardial stunning) and irreversible myocardial necrosis seen after myocardial ischemia-reperfusion (I/R) injury. Using an experimental in vivo rat model and a multi-omics approach, this work explored molecular responses following IPC and I/R. IPC was associated with reduced infarct size and a greater tendency toward reversible post-ischemic dysfunction. This effect was accompanied by early changes in phosphorylation of proteins involved in the sarcomere, Z-disc, cytoskeleton, and actin binding structures, consistent with rapid adjustment of contractile machinery during ischemic stress.
Beyond these early phosphorylation-dependent changes, IPC was associated with a
temporal proteomic response. Early adaptive pathways were activated, whereas proteins
linked to inflammation, complement, coagulation, and remodeling were attenuated
during reperfusion, suggesting a more favorable post-ischemic myocardial
environment. At the level of gene regulation, IPC was associated with transcriptional
and epigenetic reprogramming, including reduced global DNA methyltransferase
activity and selective promoter methylation changes in genes involved in inflammation,
stress signaling, and DNA repair. These changes were consistent with suppression of
maladaptive responses and activation of protective molecular programs.
In addition, plasma profiling in women identified differences in inflammatory and
stress-response protein signatures in patients with Takotsubo syndrome compared to
ST-elevation myocardial infarction. The findings of this thesis are consistent with the
concept of myocardial stunning as a biologically regulated and potentially adaptive
state.
Description
Keywords
Citation
ISBN
978-91-8115-744-4 (PDF)
Articles
II. Kakaei Y, Hussain S, Elmahdy A, et al. Comparison of the proteomic landscape in experimental ischemia–reperfusion with versus without ischemic preconditioning. Sci Rep. 2025;15:11836. http://doi.org/10.1038/s41598-025-90735-4
III. Khan AW, Hussain S, Elmahdy A, Kakaei Y, et al. Ischemic preconditioning regulates cardiac transcriptome via DNA methylation conferring cardioprotection from ischemia–reperfusion injury. Eur Heart J Open. 2025;5:oeaf124. http://doi.org/10.1093/ehjopen/oeaf124
IV. Kakaei Y, Kalani M, Jha S, et al. Temporal plasma proteomic differences between Takotsubo syndrome and ST-elevation myocardial infarction identified by proximity extension assay. Manuscript